Skip to main content
Have a personal or library account? Click to login
Clinical Approach to Evaluation of Underlying Cardiac Device Infection in Patients Hospitalized with Bacteremia Cover

Clinical Approach to Evaluation of Underlying Cardiac Device Infection in Patients Hospitalized with Bacteremia

Open Access
|Aug 2023

References

  1. Buch E, Boyle NG, Belott PH. Pacemaker and defibrillator lead extraction. Circulation. 2011 Mar 22;123(11):e378-80. doi: 10.1161/CIRCULATIONAHA.110.987354
  2. Dai M, Cai C, Vaibhav V, et al. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study. JACC Clin Electrophysiol. 2019 Sep;5(9):1071-1080. doi: 10.1016/j.jacep.2019.06.016
  3. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 8;49(18):1851-9. doi: 10.1016/j.jacc.2007.01.072
  4. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006 Aug 1;48(3):590-1. doi: 10.1016/j.jacc.2006.05.016
  5. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6. doi: 10.1016/j.jacc.2011.04.033
  6. Greenspon AJ, Eby EL, Petrilla AA, Sohail MR. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol. 2018 May;41(5):495-503. doi: 10.1111/pace.13300
  7. Khaloo P, Uzomah UA, Shaqdan A, et al. Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017. J Am Heart Assoc. 2022 Sep 6;11(17):e025600. doi: 10.1161/JAHA.122.025600
  8. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015 May;17(5):767-77. doi: 10.1093/europace/euv053
  9. Sohail MR, Eby EL, Ryan MP, Gunnarsson C, Wright LA, Greenspon AJ. Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation. Circ Arrhythm Electrophysiol. 2016 Aug;9(8):e003929. doi: 10.1161/CIRCEP.116.003929
  10. Sridhar AR, Lavu M, Yarlagadda V, et al. Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S. Pacing Clin Electrophysiol. 2017 Mar;40(3):286-293. doi: 10.1111/pace.13009
  11. Da Costa A, Lelievre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation. 1998 May 12;97(18):1791-5. doi: 10.1161/01.cir.97.18.1791
  12. Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246
  13. Hussein AA, Baghdy Y, Wazni OM, et al. Microbiology of Cardiac Implantable Electronic Device Infections. JACC Clin Electrophysiol. 2016 Aug;2(4):498-505. doi: 10.1016/j.jacep.2016.01.019
  14. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001 Aug 28;104(9):1029-33. doi: 10.1161/hc3401.095097
  15. Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010 Apr;33(4):407-13. doi: 10.1111/j.1540-8159.2009.02565.x
  16. Camus C, Leport C, Raffi F, Michelet C, Cartier F, Vilde JL. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis. 1993 Jul;17(1):46-55. doi: 10.1093/clinids/17.1.46
  17. Sohail MR, Palraj BR, Khalid S, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015 Feb;8(1):137-44. doi: 10.1161/CIRCEP.114.002199
  18. Nakajima I, Narui R, Tokutake K, et al. Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection. Heart Rhythm. 2021 May;18(5):752-759. doi: 10.1016/j.hrthm.2020.12.011
  19. Obeid KM, Szpunar S, Khatib R. Long-term outcomes of cardiovascular implantable electronic devices in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2012 Aug;35(8):961-5. doi: 10.1111/j.1540-8159.2012.03438.x
  20. Viola GM, Awan LL, Ostrosky-Zeichner L, Chan W, Darouiche RO. Infections of cardiac implantable electronic devices: a retrospective multicenter observational study. Medicine (Baltimore). 2012 May;91(3):123-130. doi: 10.1097/MD.0b013e31825592a7
  21. Bekeris LG, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med. 2005 Oct;129(10):1222-5. doi: 10.5858/2005-129-1222-TIBCCA
  22. Fowler VG, Durack DT, Selton-Suty C, et al. The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis. 2023 May 4;ciad271. doi: 10.1093/cid/ciad271
  23. Madhavan M, Sohail MR, Friedman PA, et al. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol. 2010 Dec;3(6):639-45. doi: 10.1161/CIRCEP.110.957514
  24. Chesdachai S, Baddour LM, Sohail MR, et al. Bacteremia due to non- Staphylococcus aureus gram-positive cocci and risk of cardiovascular implantable electronic device infection. Heart Rhythm O2. 2022 Dec 22;4(3):207-214. doi: 10.1016/j.hroo.2022.12.010
  25. Oh TS, Le K, Baddour LM, Sohail MR, et al. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019 Oct;42(10):1331-1339. doi: 10.1111/pace.13783
  26. Berge A, Arkel L, Nilson B, Rasmussen M. Enterococcus faecalis bacteremia, cardiac implantable electronic device, extraction, and the risk of recurrence. Infection. 2022 Dec;50(6):1517-1523. doi: 10.1007/s15010-022-01838-3
  27. Viola GM, Awan LL, Darouiche RO. Nonstaphylococcal infections of cardiac implantable electronic devices. Circulation. 2010 May 18;121(19):2085-91. doi: 10.1161/CIRCULATIONAHA.110.936708
  28. Bongiorni MG, Tascini C, Tagliaferri E, et al. Microbiology of cardiac implantable electronic device infections. Europace. 2012 Sep;14(9):1334-9. doi: 10.1093/europace/eus044
  29. Uslan DZ, Sohail MR, Friedman PA, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006 Sep 15;43(6):731-6. doi: 10.1086/506942
  30. Maskarinec SA, Thaden JT, Cyr DD, Ruffin F, Souli M, Fowler VG. The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort. Open Forum Infect Dis. 2017 Jun 21;4(3):ofx132. doi: 10.1093/ofid/ofx132
  31. Chesdachai S, Baddour LM, Sohail MR, et al. Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia. Open Forum Infect Dis. 2022 Aug 25;9(9):ofac444. doi: 10.1093/ofid/ofac444
  32. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000 Oct 17;133(8):604-8. doi: 10.7326/0003-4819-133-8-200010170-00011
  33. Massoure PL, Reuter S, Lafitte S, et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol. 2007 Jan;30(1):12-9. doi: 10.1111/j.1540-8159.2007.00574.x
  34. Victor F, De Place C, Camus C, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart. 1999 Jan;81(1):82-7. doi: 10.1136/hrt.81.1.82
  35. Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol. 1998 Aug 15;82(4):480-4. doi: 10.1016/s0002-9149(98)00365-8
  36. Patel NJ, Singleton MJ, Brunetti R, Richardson KM, Bhave PD. Evaluation of lead-based echodensities on transesophageal echocardiogram in patients with cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2023 Jan;34(1):7-13. doi: 10.1111/jce.15727
  37. George MP, Esquer Garrigos Z, Vijayvargiya P, et al. Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device Lead Vegetations Versus Noninfectious Echodensities. Clin Infect Dis. 2021 Jun 1;72(11):1938-1943. doi: 10.1093/cid/ciaa472
  38. Mahmood M, Kendi AT, Farid S, et al. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019 Jun;26(3):958-970. doi: 10.1007/s12350-017-1063-0
  39. Wang TKM, Sánchez-Nadales A, Igbinomwanhia E, Cremer P, Griffin B, Xu B. Diagnosis of Infective Endocarditis by Subtype Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Contemporary Meta-Analysis. Circ Cardiovasc Imaging. 2020 Jun;13(6):e010600. doi: 10.1161/CIRCIMAGING.120.010600
  40. Pizzi MN, Dos-Subirà L, Roque A, et al. 18F-FDG-PET/CT angiography in the diagnosis of infective endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material. Int J Cardiol. 2017 Dec 1;248:396-402. doi: 10.1016/j.ijcard.2017.08.008
  41. Chen W, Sajadi MM, Dilsizian V. Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections. JACC Cardiovasc Imaging. 2018 Nov;11(11):1679-1691. doi: 10.1016/j.jcmg.2018.08.026
  42. Sarrazin JF, Philippon F, Trottier M, Tessier M. Role of radionuclide imaging for diagnosis of device and prosthetic valve infections. World J Cardiol. 2016 Sep 26;8(9):534-546. doi: 10.4330/wjc.v8.i9.534
  43. Erba PA, Sollini M, Conti U, et al. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. JACC Cardiovasc Imaging. 2013 Oct;6(10):1075-1086. doi: 10.1016/j.jcmg.2013.08.001
  44. Kim IC, Chang S, Hong GR, et al. Comparison of Cardiac Computed Tomography With Transesophageal Echocardiography for Identifying Vegetation and Intracardiac Complications in Patients With Infective Endocarditis in the Era of 3-Dimensional Images. Circ Cardiovasc Imaging. 2018 Mar;11(3):e006986. doi: 10.1161/CIRCIMAGING.117.006986
  45. Oliveira M, Guittet L, Hamon M, Hamon M. Comparative Value of Cardiac CT and Transesophageal Echocardiography in Infective Endocarditis: A Systematic Review and Meta-Analysis. Radiol Cardiothorac Imaging. 2020 Jun 18;2(3):e190189. doi: 10.1148/ryct.2020190189
  46. Feuchtner GM, Stolzmann P, Dichtl W, et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol. 2009 Feb 3;53(5):436-44. doi: 10.1016/j.jacc.2008.01.077
  47. Le KY, Sohail MR, Friedman PA, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011 Nov;8(11):1678-85. doi: 10.1016/j.hrthm.2011.05.015
  48. Chesdachai S, Baddour LM, Sohail MR, et al. Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia. Heart Rhythm. 2022 Apr;19(4):570-577. doi: 10.1016/j.hrthm.2021.12.013
  49. Urien JM, Camus C, Leclercq C, et al. The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis. Infection. 2021 Oct;49(5):999-1006. doi: 10.1007/s15010-021-01634-5
DOI: https://doi.org/10.14797/mdcvj.1271 | Journal eISSN: 1947-6108
Language: English
Page range: 48 - 57
Submitted on: Jun 22, 2023
Accepted on: Jun 26, 2023
Published on: Aug 1, 2023
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2023 Dierdre B. Axell-House, Sarwat Khalil, M. Rizwan Sohail, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.